Compare TRMK & AXGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | TRMK | AXGN |
|---|---|---|
| Founded | 1889 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.6B | 2.3B |
| IPO Year | 1994 | 2013 |
| Metric | TRMK | AXGN |
|---|---|---|
| Price | $45.89 | $45.18 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 2 | 9 |
| Target Price | ★ $44.50 | $42.33 |
| AVG Volume (30 Days) | 362.8K | ★ 1.1M |
| Earning Date | 04-28-2026 | 04-28-2026 |
| Dividend Yield | ★ 2.26% | N/A |
| EPS Growth | ★ 1.93 | N/A |
| EPS | ★ 0.95 | N/A |
| Revenue | N/A | ★ $225,208,000.00 |
| Revenue This Year | $9.82 | $20.57 |
| Revenue Next Year | $4.86 | $16.68 |
| P/E Ratio | $48.04 | ★ N/A |
| Revenue Growth | N/A | ★ 20.21 |
| 52 Week Low | $35.96 | $10.50 |
| 52 Week High | $46.34 | $45.98 |
| Indicator | TRMK | AXGN |
|---|---|---|
| Relative Strength Index (RSI) | 59.14 | 63.62 |
| Support Level | $43.20 | $29.48 |
| Resistance Level | N/A | N/A |
| Average True Range (ATR) | 0.89 | 2.10 |
| MACD | 0.09 | 0.23 |
| Stochastic Oscillator | 80.10 | 84.26 |
Trustmark Corp is a bank holding company. Through its subsidiaries, the company operates as a financial services organization providing banking and other financial solutions in Alabama, Florida, Mississippi, Tennessee, and Texas. Its principal products and services include Commercial Banking, Consumer Banking, Mortgage Banking, Insurance, Wealth Management and Trust Services, and others. The company is managed along two operating segments: General Banking and Wealth Management. The General Banking segment, which generates the majority of the revenue, provides all traditional banking products and services, including loan deposits, and also consists of internal operations.
Axogen Inc is engaged in the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. The company provides clinically and economically effective repair solutions for surgeons and health care providers. Its products include Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard Nerve Cap, and Avive Soft Tissue Membrane. It also offers an Axotouch Two-Point Discriminator used to measure the innervation density of any surface area of the skin. Its products are available in the United States, Canada, Germany, the United Kingdom, Spain, and several other countries.